Thermo Fisher Scientific acquires Dionex

Reviewed

From Thermo Fisher Scientific Inc.May 18 2011

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation (NASDAQ: DNEX) through a short-form merger.

Pursuant to the terms of the merger, all outstanding Dionex shares (other than those held by Thermo Fisher, Dionex or any wholly owned subsidiary of Dionex, and any shareholders who validly exercised their appraisal rights in connection with the merger) will be exchanged for $118.50 per share in cash.

Source:

Thermo Fisher Scientific

Posted in: Business / Finance | Life Sciences News

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Thermo Fisher Scientific Inc.. (2019, June 19). Thermo Fisher Scientific acquires Dionex. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx.
MLA
Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific acquires Dionex". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx>.
Chicago
Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific acquires Dionex". News-Medical. https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx. (accessed December 22, 2024).
Harvard
Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific acquires Dionex. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx.